GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Tekla Healthcare Opportunities Fund (NYSE:THQ) » Definitions » Graham Number

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Graham Number : $24.08 (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is Tekla Healthcare Opportunities Fund Graham Number?

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2024-05-12), the stock price of Tekla Healthcare Opportunities Fund is $20.29. Tekla Healthcare Opportunities Fund's graham number for the quarter that ended in Sep. 2023 was $24.08. Therefore, Tekla Healthcare Opportunities Fund's Price to Graham Number ratio for today is 0.84.

The historical rank and industry rank for Tekla Healthcare Opportunities Fund's Graham Number or its related term are showing as below:

THQ' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.45   Med: 0.57   Max: 0.85
Current: 0.84

During the past 7 years, the highest Price to Graham Number ratio of Tekla Healthcare Opportunities Fund was 0.85. The lowest was 0.45. And the median was 0.57.

THQ's Price-to-Graham-Number is ranked worse than
54.68% of 1132 companies
in the Asset Management industry
Industry Median: 0.77 vs THQ: 0.84

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Tekla Healthcare Opportunities Fund Graham Number Historical Data

The historical data trend for Tekla Healthcare Opportunities Fund's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tekla Healthcare Opportunities Fund Graham Number Chart

Tekla Healthcare Opportunities Fund Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Graham Number
Get a 7-Day Free Trial - 35.87 50.05 - 24.08

Tekla Healthcare Opportunities Fund Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.05 38.15 - - 24.08

Competitive Comparison of Tekla Healthcare Opportunities Fund's Graham Number

For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tekla Healthcare Opportunities Fund's Price-to-Graham-Number Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Tekla Healthcare Opportunities Fund's Price-to-Graham-Number falls into.



Tekla Healthcare Opportunities Fund Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Tekla Healthcare Opportunities Fund's Graham Number for the fiscal year that ended in Sep. 2023 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*20.131*1.28)
=24.08

Tekla Healthcare Opportunities Fund's Graham Number for the quarter that ended in Sep. 2023 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*20.131*1.28)
=24.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tekla Healthcare Opportunities Fund  (NYSE:THQ) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Tekla Healthcare Opportunities Fund's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Sep. 2023 )
=20.29/24.08
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Tekla Healthcare Opportunities Fund Graham Number Related Terms

Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's Graham Number provided by GuruFocus.com. Please click on the following links to see related term pages.


Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Executives
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103

Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Headlines

From GuruFocus

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 03-31-2023

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 01-10-2023

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 11-30-2022

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 08-31-2022

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 04-28-2023

Tekla Healthcare Opportunities Fund Paid Distribution

By Business Wire Business Wire 02-28-2023

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 02-10-2023

Tekla Healthcare Opportunities Fund Declares Monthly Cash Distribution

By Business Wire Business Wire 06-09-2023